Literature DB >> 11836279

GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men.

Kai Henrik Wiborg Lange1, Jesper Løvind Andersen, Nina Beyer, Fredrik Isaksson, Benny Larsson, Michael Højby Rasmussen, Anders Juul, Jens Bülow, Michael Kjaer.   

Abstract

GH administration, either alone or combined with resistance exercise training (RT), has attracted interest as a means of increasing muscle mass and strength in the elderly. In the present study, 31 healthy, elderly men [age, 74 +/- 1 yr (mean +/- SEM)] were assigned to either RT [3 sessions/wk, 3-5 sets of 8-12 repetition maximum (RM)/session] + placebo (n = 8), RT + GH (n = 8), GH (n = 8), or placebo (n = 7) in a randomized, placebo-controlled, double-blinded (RT + placebo and RT + GH) or single-blinded (GH or placebo) design. Measurements of: 1) isokinetic quadriceps muscle strength; 2) quadriceps muscle power; 3) quadriceps muscle fiber type, size, and myosin heavy chain (MHC) composition; 4) quadriceps cross-sectional area (CSA) [nuclear magnetic resonance imaging (NMRI)]; 5) body composition (dual-energy x-ray absorptiometry scanning); and 6) GH-related serum markers were performed at baseline and after 12 wk. The final GH dose was 1.77 +/- 0.18 IU x d(-1) (approximately 7.2 +/- 0.8 microg x kg(-1) x d(-1)). GH alone had no effect on isokinetic quadriceps muscle strength, power, CSA, or fiber size. However, a substantial increase in MHC 2X isoform was observed with GH administration alone, and this may be regarded as a change into a more youthful MHC composition, possibly induced by the rejuvenating of systemic IGF-I levels. RT + placebo caused substantial increases in quadriceps isokinetic strength, power, and CSA; but these RT induced improvements were not further augmented by additional GH administration. In the RT + GH group, there was a significant decrease in MHC 1 and 2X isoforms, whereas MHC 2A increased. RT, therefore, seems to overrule the changes in MHC composition induced by GH administration alone. Changes in body composition confirmed previous reports of decreased fat mass, increased fat-free mass, and unchanged bone mineral content with GH administration. A high incidence of side effects was reported. Our results do not support a role for GH as a means of increasing muscle strength or mass, either alone or combined with RT, in healthy elderly men; although GH administration alone may induce changes in MHC composition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836279     DOI: 10.1210/jcem.87.2.8206

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  46 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice.

Authors:  Jacob A Panici; James M Harper; Richard A Miller; Andrzej Bartke; Adam Spong; Michal M Masternak
Journal:  FASEB J       Date:  2010-08-18       Impact factor: 5.191

3.  Hypertrophy with unilateral resistance exercise occurs without increases in endogenous anabolic hormone concentration.

Authors:  Sarah B Wilkinson; Mark A Tarnopolsky; Emily J Grant; Caroline E Correia; Stuart M Phillips
Journal:  Eur J Appl Physiol       Date:  2006-09-14       Impact factor: 3.078

Review 4.  Hormonal regulation of longevity in mammals.

Authors:  Holly M Brown-Borg
Journal:  Ageing Res Rev       Date:  2007-02-20       Impact factor: 10.895

Review 5.  Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia.

Authors:  G Onder; C Della Vedova; F Landi
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

Review 6.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 7.  Skeletal muscle changes after hemiparetic stroke and potential beneficial effects of exercise intervention strategies.

Authors:  Charlene E Hafer-Macko; Alice S Ryan; Frederick M Ivey; Richard F Macko
Journal:  J Rehabil Res Dev       Date:  2008

8.  Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men.

Authors:  Thomas Münzer; S Mitchell Harman; John D Sorkin; Marc R Blackman
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

Review 9.  Optimal management of sarcopenia.

Authors:  Louise A Burton; Deepa Sumukadas
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

10.  Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis.

Authors:  Simon Doessing; Katja M Heinemeier; Lars Holm; Abigail L Mackey; Peter Schjerling; Michael Rennie; Kenneth Smith; Søren Reitelseder; Anne-Marie Kappelgaard; Michael Højby Rasmussen; Allan Flyvbjerg; Michael Kjaer
Journal:  J Physiol       Date:  2009-11-23       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.